Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Trump Press Conference Turns Into 2028 Succession Audition

    November 21, 2026

    Study: Escitalopram, Duloxetine Outperform Fluoxetine for Long-Term Depression

    November 21, 2026

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      Study: Escitalopram, Duloxetine Outperform Fluoxetine for Long-Term Depression

      November 21, 2026

      US, Mexico, Bolivia Lose Measles-Free Status as Global Cases Rise

      November 20, 2026

      The Opera Coat Trend Takes Over Winter Fashion

      November 20, 2026

      New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

      November 20, 2026

      Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

      November 20, 2026
    • Relations

      Trump Press Conference Turns Into 2028 Succession Audition

      November 21, 2026

      US Lawmakers Seek Stricter AI Chip Export Controls

      November 20, 2026

      Trump Threatens Tax on US Tech Firms Building AI Data Centers Abroad

      November 20, 2026

      Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

      November 20, 2026

      Xi Jinping’s Restraint: The Power of Not Acting in Shenzhen

      November 20, 2026
    • Technology

      Germany Proposes €25 Billion Buyout of TikTok Europe

      November 20, 2026

      AI Supply Chain Leaks 2 Million Secrets in Canary Test

      November 20, 2026

      Google to retire Nest app in January 2027

      November 20, 2026

      Microsoft Link to Windows Adds Second Screen Feature

      November 20, 2026

      Nothing Sets December 8 Date for AI Hardware Reveal

      November 20, 2026
    • Travel & Tourism

      TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

      November 20, 2026

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026

      Riyadh Hotel Revenue Plummets 65% After Airport Attack

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»Injectable Nerve Device Targets Chronic Pain Without Surgery
    Health

    Injectable Nerve Device Targets Chronic Pain Without Surgery

    im.newsBy im.newsOctober 11, 2026No Comments4 Mins Read17 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Seed-sized injectable nerve device for chronic pain treatment
    Photo: Politikaner / Wikimedia Commons, CC BY-SA 3.0
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Researchers at NYU Abu Dhabi and Cleveland Clinic Abu Dhabi have developed a miniature medical device capable of regulating nerve activity through injection rather than surgery. The technology, described in a recent study published in Science Advances, offers a potentially less invasive alternative for treating chronic pain and movement disorders.

    The device is roughly the size of a small seed. It is delivered through a standard needle and positioned close to a specific nerve. Once in place, it sends carefully controlled electrical signals that alter the nerve’s activity. Power is supplied wirelessly from outside the body, allowing doctors or patients to adjust the stimulation in real time.

    NYU Abu Dhabi Seed-Sized Implant

    Current treatments for nerve-related conditions often involve medications or surgically implanted devices that require batteries and connecting wires. This new approach removes those barriers. The device operates without internal power sources or physical connections, reducing the complexity of the procedure.

    Prof. Khalil Ramadi, Assistant Professor of Bioengineering at NYU Abu Dhabi and NYU Tandon, emphasized the shift in treatment methodology. “This work represents a shift in how we think about treating nerve-related conditions,” Ramadi said. “By creating a device that can be injected rather than surgically implanted, we are making these therapies simpler, safer, and more accessible, while still maintaining precise control over nerve activity.”

    Beveled tip of a hypodermic needle 20090714 006
    Photo: Politikaner / Wikimedia Commons, CC BY-SA 3.0

    The device provides programmable electrical stimulation. This means the signals it delivers can be adjusted to suit a patient’s specific needs. Healthcare providers can modify the intensity and frequency of the stimulation to manage conditions involving abnormal or unwanted nerve activity.

    Imaging and Preclinical Testing Results

    A key advantage of this technology is its visibility during medical imaging. Doctors can locate and monitor the device using familiar techniques, including ultrasound and computed tomography (CT) scans. These methods help guide placement near the intended nerve and allow the device’s position to be checked afterward.

    The research team evaluated the technology through laboratory experiments and preclinical testing. Their results showed that the miniature device could deliver precise nerve stimulation while maintaining consistent performance under conditions designed to resemble real-world use. The team also demonstrated that the device could successfully activate nerves in vivo, meaning within a living organism rather than only in an isolated laboratory setting.

    Dr. Mohamed Elsherif, Research Associate at NYU Abu Dhabi and the study’s first author, noted the potential impact on patient care. “This technology has the potential to bridge the gap between non-invasive therapies and traditional implants,” Elsherif said. “It opens the door to treatments that are both effective and easy to deliver, which could significantly improve patient care.”

    Sakralnerv  Blasen  Stimulator 29W   CT   001
    Photo: Hellerhoff / Wikimedia Commons, CC BY-SA 4.0

    Dr. Sawsan Abdel-Razig, Chief Academic Officer at Cleveland Clinic Abu Dhabi, highlighted the collaborative nature of the project. “This collaboration with NYU Abu Dhabi reflects our commitment to advancing innovative, clinically relevant research that translates into meaningful improvements in patient care,” she said. “By bringing together multidisciplinary expertise, this work highlights how academic partnerships can accelerate the development of safer, less invasive therapies and expand access to advanced treatments for patients.”

    Although the device has demonstrated promising results in early testing, its ability to relieve chronic pain or improve movement disorders in human patients has not yet been established. If further research confirms its safety and effectiveness, the technology could reduce the need for more invasive procedures. Avoiding surgical implantation could also help decrease procedure-related risks and shorten recovery times.

    Additional contributors to the study from NYU Abu Dhabi included Salma Mansour, Zhansaya Makhambetova, Fotoon Aldhanhani, Batoul Khlaifat, Mahmoud Elbeh, Vega Pradana Rachim, and Sohmyung Ha. The Cleveland Clinic Abu Dhabi co-authors were Hicham Abada, Juan S. Barajas-Gamboa, and Carlos M. Abril Vega.

    Source: ScienceDaily

    chronic pain Cleveland Clinic Health health technology medical devices nerve stimulation NYU Abu Dhabi
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleLancet Commission: AI and Nuclear Risks Threaten Humanity by 2100
    Next Article Netflix Uses AI on 300 Titles, Emphasizes Human Creativity
    im.news

    Related Posts

    Trump Press Conference Turns Into 2028 Succession Audition

    November 21, 2026

    Study: Escitalopram, Duloxetine Outperform Fluoxetine for Long-Term Depression

    November 21, 2026

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    Trump Press Conference Turns Into 2028 Succession Audition

    November 21, 20261 Views

    Study: Escitalopram, Duloxetine Outperform Fluoxetine for Long-Term Depression

    November 21, 20263 Views

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 20263 Views

    US Lawmakers Seek Stricter AI Chip Export Controls

    November 20, 20263 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    Trump Press Conference Turns Into 2028 Succession Audition

    November 21, 2026

    Study: Escitalopram, Duloxetine Outperform Fluoxetine for Long-Term Depression

    November 21, 2026

    Curiosity Rover Captures Rare Twilight Clouds on Mars

    November 20, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.